C. Aninat, A. Piton, D. Glaise, T. Le-charpentier, S. Langouët et al., EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS, Drug Metabolism and Disposition, vol.34, issue.1, pp.75-83, 2006.
DOI : 10.1124/dmd.105.006759
URL : https://hal.archives-ouvertes.fr/hal-00702085

A. Robin, Induction of Vesicular Steatosis by Amiodarone and Tetracycline Is Associated with up-Regulation of Lipogenic Genes in HepaRG Cells, Hepatology, vol.53, issue.6, pp.1895-1905, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00739358

I. M. Arias, Z. Mingxin-che, C. Gatmaitan, T. Leveille, M. Nishida et al., The biology of the bile canaliculus, 1993, Hepatology, vol.15, issue.2, pp.318-347, 1993.
DOI : 10.1042/bj2840067

. Bachour-el-azzi, A. Pamela, A. Sharanek, R. Burban, R. L. Li et al., Comparative Localization and Functional Activity of the Main Hepatobiliary Transporters in HepaRG Cells and Primary Human Hepatocytes, Toxicological Sciences, vol.145, issue.1, pp.157-68, 2015.
DOI : 10.1093/toxsci/kfv041
URL : https://hal.archives-ouvertes.fr/hal-01134682

D. Hepatotoxicity, Analysis of 180 Cases Reported to the Food and Drug Administration as Adverse Reactions, Hepatology, vol.22, issue.3, pp.820-847

S. Bramow, P. Ott, F. Thomsen-nielsen, K. Bangert, N. Tygstrup et al., Cholestasis and Regulation of Genes Related to Drug Metabolism and Biliary Transport in Rat Liver Following Treatment with Cyclosporine A and Sirolimus (Rapamycin), Pharmacology & Toxicology, vol.89, issue.3, pp.133-172, 2001.
DOI : 10.1111/j.1600-0773.2001.890304.x

K. L. Brouwer, D. Keppler, K. A. Hoffmaster, D. J. Bow, Y. Cheng et al., In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development, Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development, pp.95-112
DOI : 10.1093/toxsci/kfq269

V. Cerec, D. Glaise, D. Garnier, S. Morosan, B. Turlin et al., Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor, Hepatology, vol.103, issue.4, pp.957-67, 2007.
DOI : 10.1007/s004180100310
URL : https://hal.archives-ouvertes.fr/hal-00690471

S. Hafey and . Xu, Transport of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin by Human Organic Anion Transporter 3, Organic Anion Transporting Polypeptide 4C1, and Multidrug Resistance P-Glycoprotein, The Journal of Pharmacology and Experimental Therapeutics, vol.321, issue.2, pp.673-83, 2007.

W. Choi and B. M. Ahn, Increased Microfilaments in Hepatocytes and Biliary Ductular Cells in Cholestatic Liver Diseases, Journal of Korean Medical Science, vol.17, issue.6, pp.795-800, 2002.

S. Dawson, S. Stahl, N. Paul, J. Barber, and J. G. Kenna, In Vitro Inhibition of the Bile Salt Export Pump Correlates with Risk of Cholestatic Drug-Induced Liver Injury in Humans, Drug Metabolism and Disposition, vol.40, issue.1, pp.130-168, 2012.
DOI : 10.1124/dmd.111.040758

S. Dhillon and G. M. Keating, Bosentan, American Journal Cardiovascular Drugs, vol.103, issue.7, pp.331-50, 2009.
DOI : 10.1164/ajrccm.165.6.2106079

M. G. Donner and D. Keppler, Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver, Hepatology, vol.34, issue.2, pp.351-59, 2001.
DOI : 10.1053/jhep.2001.26213

M. C. Xu, A. R. Dunn, Y. Smith, and . Will, In Vitro Assessment of Mitochondrial Dysfunction and Cytotoxicity of Nefazodone, Trazodone, and Buspirone, Toxicological Sciences: An Official Journal of the Society of Toxicology, vol.103, issue.2, pp.335-380, 2008.

L. C. Ellis, M. H. Grant, G. M. Hawksworth, and R. J. Weaver, Quantification of biliary excretion and sinusoidal excretion of 5(6)-carboxy-2???,7???-dichlorofluorescein (CDF) in cultured hepatocytes isolated from Sprague Dawley, Wistar and Mrp2-deficient Wistar (TR???) rats, Toxicology in Vitro, vol.28, issue.6, pp.1165-75, 2014.
DOI : 10.1016/j.tiv.2014.05.010

G. Feuer and C. J. Di-fonzo, INTRAHEPATIC CHOLESTASIS: A REVIEW OF BIOCHEMICAL-PATHOLOGICAL MECHANISMS, Drug Metabolism and Drug Interactions, vol.44, issue.1, pp.1-161, 1992.
DOI : 10.1016/0041-008X(76)90072-7

A. Fisher, J. Croft-baker, M. Davis, P. Purcell, and A. J. Mclean, Entacapone-Induced Hepatotoxicity and Hepatic Dysfunction, Movement Disorders, vol.28, issue.6, pp.1362-65, 2002.
DOI : 10.1002/mds.10342

D. Fromenty, B. , and D. Pessayre, Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity, Pharmacology & Therapeutics, vol.67, issue.1, pp.101-54, 1995.
DOI : 10.1016/0163-7258(95)00012-6

B. Garzel, H. Yang, L. Zhang, S. Huang, J. E. Polli et al., The Role of Bile Salt Export Pump Gene Repression in Drug-Induced Cholestatic Liver Toxicity, Drug Metabolism and Disposition, vol.42, issue.3, pp.318-340, 2014.
DOI : 10.1124/dmd.113.054189

J. Graf, A. Gautam, and J. L. Boyer, Isolated rat hepatocyte couplets: a primary secretory unit for electrophysiologic studies of bile secretory function., Proceedings of the National Academy of Sciences, vol.81, issue.20, pp.6516-6536, 1984.
DOI : 10.1073/pnas.81.20.6516

C. Guguen-guillouzo, J. P. Campion, P. Brissot, D. Glaise, B. Launois et al., High yield preparation of isolated human adult hepatocytes by enzymatic perfusion of the liver, Cell Biology International Reports, vol.6, issue.6, pp.625-653, 1982.
DOI : 10.1016/0309-1651(82)90187-4

C. Guguen-guillouzo and A. Guillouzo, General Review on In Vitro Hepatocyte Models and Their Applications, Methods in Molecular Biology N.J.), vol.640, pp.1-40, 2010.
DOI : 10.1007/978-1-60761-688-7_1
URL : https://hal.archives-ouvertes.fr/hal-00742202

H. Imanari, H. Kuroda, and K. Tamura, Microfilaments around the Bile Canaliculi in Patients with Intrahepatic Cholestasis, Gastroenterologia Japonica, vol.16, issue.2, pp.168-73, 1981.

P. L. Jansen, S. S. Strautnieks, E. Jacquemin, M. Hadchouel, E. M. Sokal et al., Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis, Gastroenterology, vol.117, issue.6, pp.1370-79, 1999.
DOI : 10.1016/S0016-5085(99)70287-8

K. Jemnitz, Z. Veres, R. Tugyi, and L. Vereczkey, Biliary Efflux Transporters Involved in the Clearance of Rosuvastatin in Sandwich Culture of Primary Rat Hepatocytes. Toxicology in Vitro, An International Journal Published in Association with BIBRA, vol.24, issue.2, pp.605-615, 2010.

R. Kaimal, X. Song, B. Yan, R. King, and R. Deng, Differential Modulation of Farnesoid X Receptor Signaling Pathway by the Thiazolidinediones, Journal of Pharmacology and Experimental Therapeutics, vol.330, issue.1, pp.125-159, 2009.
DOI : 10.1124/jpet.109.151233

M. Keisu and T. B. Andersson, Drug-Induced Liver Injury in Humans: The Case of Ximelagatran, Handbook of Experimental Pharmacology, issue.196, pp.407-425, 2010.
DOI : 10.1007/978-3-642-00663-0_13

J. Kenna and . Gerry, Current Concepts in Drug-Induced Bile Salt Export Pump (BSEP) Interference, Current Protocols in Toxicology, vol.287, pp.23-30, 2014.
DOI : 10.1074/jbc.M111.329318

K. Kenne, I. Skanberg, B. Glinghammar, A. Berson, D. Pessayre et al., Prediction of drug-induced liver injury in humans by using in vitro methods: The case of ximelagatran, Toxicology in Vitro, vol.22, issue.3, pp.730-776, 2008.
DOI : 10.1016/j.tiv.2007.11.014

K. Köck, B. C. Ferslew, I. Netterberg, K. Yang, T. J. Urban et al., Risk Factors for Development of Cholestatic Drug-Induced Liver Injury: Inhibition of Hepatic Basolateral Bile Acid Transporters Multidrug Resistance-Associated Proteins 3 and 4, Drug Metabolism and Disposition, vol.42, issue.4, 2014.
DOI : 10.1124/dmd.113.054304

S. E. Kostrubsky, C. Stephen, A. S. Strom, S. Kalgutkar, J. Kulkarni et al., Inhibition of Hepatobiliary Transport as a Predictive Method for Clinical Hepatotoxicity of Nefazodone, Toxicological Sciences, vol.90, issue.2, 2006.
DOI : 10.1093/toxsci/kfj095

W. M. Lee, Drug-Induced Hepatotoxicity, New England Journal of Medicine, vol.349, issue.5, pp.474-85, 2003.
DOI : 10.1056/NEJMra021844

M. J. Liguori, A. G. Eric, J. F. Blomme, and . Waring, Trovafloxacin-Induced Gene Expression Changes in Liver-Derived in Vitro Systems: Comparison of Primary Human Hepatocytes to HepG2 Cells, Drug Metabolism and Disposition, vol.36, issue.2, pp.223-256, 2008.
DOI : 10.1124/dmd.107.017608

D. Longo, P. Yang, B. Watkins, S. Howell, and . Siler, , a Mechanistic Model of Drug-Induced Liver Injury, CPT: Pharmacometrics & Systems Pharmacology, vol.51, issue.suppl. 2, pp.31-39, 2016.
DOI : 10.1016/j.nbd.2012.10.011

Y. Mano, T. Usui, and H. Kamimura, Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance???associated protein 2, Biopharmaceutics & Drug Disposition, vol.77, issue.1, pp.13-18, 2007.
DOI : 10.1002/bdd.527

L. D. May, H. Jay, M. T. Lefkowitch, D. E. Kram, and . Rubin, Mixed Hepatocellular???Cholestatic Liver Injury after Pioglitazone Therapy, Annals of Internal Medicine, vol.136, issue.6, pp.449-52, 2002.
DOI : 10.7326/0003-4819-136-6-200203190-00008

H. Curry and . Jaeschke, The Mechanism Underlying Acetaminophen- Induced Hepatotoxicity in Humans and Mice Involves Mitochondrial Damage and Nuclear DNA Fragmentation, The Journal of Clinical Investigation, vol.122, issue.4, pp.1574-83, 2012.

M. J. Mihatsch, M. Kyo, K. Morozumi, Y. Yamaguchi, V. Nickeleit et al., The Side-Effects of Ciclosporine-A and Tacrolimus, Clinical Nephrology, vol.49, issue.6, pp.356-63, 1998.

. Mohi-ud-din, J. H. Raja, and . Lewis, Drug- and chemical-induced cholestasis, Clinics in Liver Disease, vol.8, issue.1, pp.95-132, 2004.
DOI : 10.1016/S1089-3261(03)00124-7

R. E. Morgan, M. Trauner, C. J. Van-staden, P. H. Lee, B. Ramachandran et al., Interference with Bile Salt Export Pump Function Is a Susceptibility Factor for Human Liver Injury in Drug Development, Toxicological Sciences, vol.118, issue.2, pp.485-500, 2010.
DOI : 10.1093/toxsci/kfq269

R. E. Morgan, J. Carlo, Y. Van-staden, N. Chen, J. Kalyanaraman et al., A This article has not been copyedited and formatted. The final version may differ from this version, 2013.

. Nammour, E. Fadel, F. Nabil, S. R. Fayad, and . Peikin, METFORMIN-INDUCED CHOLESTATIC HEPATITIS, Endocrine Practice, vol.9, issue.4, pp.307-316, 2003.
DOI : 10.4158/EP.9.4.307

M. S. Padda, M. Sanchez, A. J. Akhtar, and J. L. Boyer, Drug-induced cholestasis, Hepatology, vol.9, issue.182, pp.1377-87, 2011.
DOI : 10.1177/014860718500900111

C. Pauli-magnus and P. J. Meier, Hepatobiliary transporters and drug-induced cholestasis, Hepatology, vol.56, issue.4, pp.778-87, 2006.
DOI : 10.1152/physrev.00027.2002

G. Pomponio, C. C. Savary, C. Parmentier, F. Bois, A. Guillouzo et al., In Vitro Kinetics of Amiodarone and Its Major Metabolite in Two Human Liver Cell Models after Acute and Repeated Treatments. Toxicology in Vitro, The Predict-IV project: Towards predictive toxicology using in vitro techniques, pp.36-51, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01134698

R. Regenthal, M. Krueger, C. Koeppel, and R. Preiss, Drug Levels: Therapeutic and Toxic Serum/plasma Concentrations of Common Drugs, Journal of Clinical Monitoring and Computing, vol.15, issue.7/8, pp.529-573, 1999.
DOI : 10.1023/A:1009935116877

T. Saadi, M. Waterman, H. Yassin, and Y. Baruch, Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review, International Journal of General Medicine, vol.6, pp.703-709, 2013.
DOI : 10.2147/IJGM.S49657

S. Schadt, S. Simon, S. Kustermann, F. Boess, C. Mcginnis et al., Minimizing DILI Risk in Drug Discovery -A Screening Tool for Drug This article has not been copyedited and formatted. The final version may differ from this version, 2015.

D. Candidates, Toxicology in Vitro, An International Journal Published in Association with BIBRA Pt B, vol.30, issue.1, pp.429-466

A. Sharanek, P. Bachour-el-azzi, H. Al-attrache, C. C. Savary, L. Humbert et al., Different Dose-Dependent Mechanisms Are Involved in Early Cyclosporine A-Induced Cholestatic Effects in HepaRG Cells, Toxicological Sciences, vol.141, issue.1, pp.244-53, 2014.
DOI : 10.1093/toxsci/kfu122
URL : https://hal.archives-ouvertes.fr/hal-01016342

A. Sharanek, A. Burban, L. Humbert, P. Bachour-el-azzi, N. Felix-gomes et al., Cellular Accumulation and Toxic Effects of Bile Acids in Cyclosporine A-Treated HepaRG Hepatocytes, Toxicological Sciences, vol.147, issue.2, pp.573-87, 2015.
DOI : 10.1093/toxsci/kfv155
URL : https://hal.archives-ouvertes.fr/hal-01187306

A. Sharanek, A. Burban, M. Burbank, R. L. Guevel, R. Li et al., Rho-kinase/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs, Scientific Reports, vol.305, issue.1, p.24709, 2016.
DOI : 10.1152/ajpgi.00082.2013
URL : https://hal.archives-ouvertes.fr/hal-01326368

K. S. Smith, L. Philip, T. N. Smith, J. M. Heady, W. D. Trugman et al., In Vitro Metabolism of Tolcapone to Reactive Intermediates:?? Relevance to Tolcapone Liver Toxicity, Chemical Research in Toxicology, vol.16, issue.2, pp.123-151, 2003.
DOI : 10.1021/tx025569n

O. Spigset, S. Hägg, and A. Bate, Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors, International Clinical Psychopharmacology, vol.18, issue.3, pp.157-61, 2003.
DOI : 10.1097/01.yic.0000066455.73432.d2

B. Stieger, Role of the bile salt export pump, BSEP, in acquired forms of cholestasis, Drug Metabolism Reviews, vol.9, issue.3, pp.437-482, 2010.
DOI : 10.1007/s10354-006-0312-7

*. Swift, N. D. Brandon, *. Pfeifer, and K. L. Brouwer, model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity, Drug Metabolism Reviews, vol.21, issue.8, pp.446-71, 2010.
DOI : 10.1016/S0168-8278(03)00096-5

N. Thibault, J. R. Claude, and F. Ballet, Actin filament alteration as a potential marker for cholestasis: a study in isolated rat hepatocyte couplets, Toxicology, vol.73, issue.3, pp.269-79, 1992.
DOI : 10.1016/0300-483X(92)90069-Q

Y. Toyoda, M. Tamai, K. Kashikura, S. Kobayashi, Y. Fujiyama et al., Acetaminophen-Induced Hepatotoxicity in a Liver Tissue Model Consisting of Primary Hepatocytes Assembling around an Endothelial Cell Network, Drug Metabolism and Disposition, vol.40, issue.1, pp.169-77, 2012.
DOI : 10.1124/dmd.111.041137

A. Treiber, R. Schneiter, S. Hausler, and B. Stieger, Bosentan Is a Substrate of Human OATP1B1 and OATP1B3: Inhibition of Hepatic Uptake as the Common Mechanism of Its Interactions with Cyclosporin A, Rifampicin, and Sildenafil, Drug Metabolism and Disposition, vol.35, issue.8, pp.1400-1407, 2007.
DOI : 10.1124/dmd.106.013615

S. Tujios and R. J. Fontana, Mechanisms of drug-induced liver injury: from bedside to bench, Nature Reviews Gastroenterology & Hepatology, vol.209, issue.4, pp.202-213, 2011.
DOI : 10.1016/j.tox.2004.12.026

L. S. Velayudham and G. C. Farrell, Drug-induced cholestasis, Expert Opinion on Drug Safety, vol.35, issue.3, pp.287-304, 2003.
DOI : 10.1001/archinte.156.12.1327

W. Paul, B. Randall, and W. Whitcomb, Hepatic Dysfunction Associated with Troglitazone, The New England Journal of Medicine, vol.338, issue.13, pp.916-933, 1998.